Arete Wealth Advisors, LLC Chroma Dex Corp. Transaction History

Arete Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.83 - $4.61 $127,134 - $207,099	-44,924 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$3.83 - $4.72 $19,150 - $23,600	-5,000 Reduced 10.02%	44,924 $177,000
Q2 2019 Aug 14, 2019	SELL	$3.71 - $4.83 $12,369 - $16,103	-3,334 Reduced 6.26%	49,924 $232,000
Q3 2018 Nov 14, 2018	SELL	$3.5 - $4.91 $29,169 - $40,919	-8,334 Reduced 13.53%	53,258 $228,000
Q2 2018 Aug 14, 2018	BUY	$3.22 - $4.43 $7,512 - $10,335	2,333 Added 3.94%	61,592 $229,000
Q4 2017 Feb 14, 2018	SELL	$3.88 - $6.96 $12,935 - $23,204	-3,334 Reduced 5.33%	59,259 $348,000
Q3 2017 Nov 15, 2017	BUY	$2.91 - $4.71 $182,145 - $294,813	62,593	62,593 $269,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $386M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arete Wealth Advisors, LLC with notifications on news.